Immunotherapy in Melanoma: Role of TIGIT and LAG-3 on the antitumor immune microenvironment
Melanoma, is a malignant tumor arising from melanocytes. Given the ability of melanoma cells to inactivate lymphocytes, immunotherapy in melanoma has focused on using immune checkpoint inhibitors (ICIs) to counteract immune evasion. The lymphocyte activation gene 3 (LAG-3) and the inhibitory recepto...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2023
- Institución:
- Universidad Pedagógica y Tecnológica de Colombia
- Repositorio:
- RiUPTC: Repositorio Institucional UPTC
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.uptc.edu.co:001/15368
- Acceso en línea:
- https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/15041
https://repositorio.uptc.edu.co/handle/001/15368
- Palabra clave:
- Anticuerpos monoclonales
Terapia antitumoral combinada
punto de control inmunitario
LAG-3
TIGIT
células T
Monoclonal antibodies
T cells
LAG-3
immune checkpoint
combined antitumor therapy
TIGIT
- Rights
- License
- http://purl.org/coar/access_right/c_abf2